Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.

Filippatos, Gerasimos; Anker, Stefan D; Butler, Javed; Farmakis, Dimitrios; Ferreira, João Pedro; Gollop, Nicholas D; Brueckmann, Martina; Iwata, Tomoko; Pocock, Stuart; Zannad, Faiez; +2 more... Packer, Milton; EMPEROR-Reduced Trial Committees and Investigators; (2022) Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced. European journal of heart failure, 24 (12). pp. 2297-2304. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.2707

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.2707

Abstract

Share

Download

Filename: Filippatos-etal-2022-Effects-of-empagliflozin-on-cardiovascular.pdf

Licence: Creative Commons: Attribution-Noncommercial 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar